MCK 📈 McKesson - Overview

Exchange: NYSE • Opening Hours • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58155Q1031

MCK: Pharmaceuticals, Medical Supplies, Technology Solutions, Logistics Services

Mckesson Corporation is a leading healthcare company that provides a wide range of services in the United States and internationally. The company operates through four distinct segments, each catering to specific needs in the healthcare industry.

The U.S. Pharmaceutical segment is a major player in the distribution of pharmaceutical drugs, including branded, generic, specialty, biosimilar, and over-the-counter medications. In addition to drug distribution, this segment offers a suite of services to community-based oncology and specialty practices, including practice management, technology, clinical support, and business solutions. It also provides consulting, outsourcing, and technological services to pharmacies, as well as financial, operational, and clinical solutions to help them optimize their operations.

The Prescription Technology Solutions (RxTS) segment focuses on addressing medication challenges for patients by connecting various stakeholders in the healthcare ecosystem, including patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. This segment offers innovative solutions to improve patient outcomes, including prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services.

The Medical-Surgical Solutions segment is dedicated to providing medical-surgical supply distribution, logistics, and other services to healthcare providers, such as physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment helps healthcare providers streamline their operations and improve patient care.

The International segment operates in Europe and Canada, providing distribution and services to wholesale, institutional, and retail customers. This segment helps to expand McKesson's reach and provide its services to a broader customer base.

With a rich history dating back to 1833, McKesson Corporation is headquartered in Irving, Texas, and has established itself as a trusted partner in the healthcare industry. To learn more about the company and its services, visit their website at https://www.mckesson.com.

Additional Sources for MCK Stock

MCK Stock Overview

Market Cap in USD 68,202m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1994-11-15

MCK Stock Ratings

Growth 5y 92.2
Fundamental 53.1
Dividend 50.8
Rel. Performance vs Sector 2.01
Analysts 4.11/5
Fair Price Momentum 740.27 USD
Fair Price DCF 937.29 USD

MCK Dividends

Dividend Yield 12m 0.41%
Yield on Cost 5y 1.74%
Dividends CAGR 5y 7.71%
Payout Consistency 96.73%

MCK Growth Ratios

Growth Correlation 3m 20.1%
Growth Correlation 12m 50.8%
Growth Correlation 5y 98.7%
CAGR 5y 33.27%
CAGR/Mean DD 5y 6.30
Sharpe Ratio 12m 1.15
Alpha vs SP500 12m 11.92
Beta vs SP500 5y weekly 0.74
Volatility GJR Garch 1y 34.60%
Current Volume 484.8k
Average Volume 20d 988.1k
What is the price of MCK stocks?
As of November 21, 2024, the stock is trading at USD 621.14 with a total of 484,842 shares traded.
Over the past week, the price has changed by -0.55%, over one month by +22.19%, over three months by +13.38% and over the past year by +37.80%.
Is McKesson a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, McKesson (NYSE:MCK) is currently (November 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.05 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MCK as of November 2024 is 740.27. This means that MCK is currently undervalued and has a potential upside of +19.18% (Margin of Safety).
Is MCK a buy, sell or hold?
  • Strong Buy: 9
  • Buy: 3
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
McKesson has received a consensus analysts rating of 4.11. Therefor, it is recommend to buy MCK.
What are the forecast for MCK stock price target?
According to ValueRays Forecast Model, MCK McKesson will be worth about 810.2 in November 2025. The stock is currently trading at 621.14. This means that the stock has a potential upside of +30.44%.
Issuer Forecast Upside
Wallstreet Target Price 583.5 -6.1%
Analysts Target Price 486.3 -21.7%
ValueRay Target Price 810.2 30.4%